Slide 1: Q1 2013 Revenue
Qi 2013 Revenue
Slide 2: Forward-looking statements
This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward- looking statements involve risk and uncertainty. Forward-looking g statements represent p the company's judgment reg
Slide 3: Copyright notice
This document should not be distributed with hout Cegedim authorization – Copyright 2013 3
Slide 4: First quarter L-f-L revenues were stable: +0.1%
First quarter L-f-L revenues were w stable: +0.1% 9 Innovation efforts and new product launches continue 9 Profitability improvement expected e from the first quarter 9 The Group reiterates its full-year target This document should not be distributed with hout Cegedim authorization – Copyright 201
Slide 5: Revenue Q1 2013
Revenue Q1 2013 9 Organic growth +0.1% 9 Currency Impact 9 Revenue Breakdown as of March 31, 2013 This document should not be distributed with hout Cegedim authorization – Copyright 2013 5
Slide 6: CRM & Strategic Data
CRM & Strategic Data 9 Growth in emerging g g 9 Q1 2013 Revenue countries continued (China, Russia) (3.0)% 49% Organic growth % of Group Rev venue 9 Revenues were less impacted by drug patent expiration and competition titi from f generic i 9 Revenue Evolution drugs 9 Slower Sl order d intake i t
Slide 7: Healthcare Professionals
Healthcare Professionals 9 Healthy y g growth in 9 Q1 2013 Revenue business related to software for healthcare 3.3% 33% professionals Organic growth % of Group Rev venue 9 Development of performance-based pay f for physicians h i i 9 Revenue Evolution 9 Cegelease continues to grow, albeit lb it ll
Slide 8: Insurance & Services
Insurance & Services Commercial success 9 Q1 2013 Revenue 3.9% 18% Insurance: Contract Organic growth % of Group Rev venue with ith FFrance’s second- d largest social welfare institution 9 Revenue Evolution SEPA: Contratc with Harmonie Mutuelle GIS (Commercial success): Contratc with Moneo Applica
Slide 9: Capital Structure Evolution
Capital Structure Evolution 9 New Bond Issued 9 Tender Offer on 2015 Bond Issuer Cegedim S.A. Repurchased price: 108% Issue Senior unsecured notes Amount repurchased: €111.5m Principal amount €300m Including accrued and unpaid Currency EUR interest: €121.5 million Maturity 7 years (2020) €
Slide 10: Capital Structure
Capital Structure 9 Capital p Structure 9 Gross Debt by y Source of Financing g 9 Credit Rating April 26, 2013: B+, Stable Outlook March 11, 2013: B, Positive credit watch October 9, 2012: B, Stable outlook This document should not be distributed with hout Cegedim authorization – Copyright 2
Slide 11: Maturity Profile
Maturity Profile 9 Before 9 After €280m €300m €169m €45m €30m €45m €40m €40m €40m €20m 2013 2014 2015 2016 2017 2018 2019 2020 2013 2014 2015 2016 2017 2018 2019 2020 Existing TL FCB Loan Existing Notes Existing RCF (Drawn) Existing TL Existing Notes FCB Loan New Notes Existing RCF (Drawn) in € mi
Slide 12: Margin Improvement target in 2013
Margin Improvement target inn 2013(1) For 2013, barring any sign nificant changes in market trends the Group reiterates its targets: trends, Revenue growth of around d 2%(2) A 50 basis b i point i t increase i in the th operating ti margin i from f recurring operations (1) These projections ar
Slide 13: Significant Growth Opportunities
Significant Growth Opportunnities This document should not be distributed with hout Cegedim authorization – Copyright 2013 13
Slide 14: Q1 2013 Results
Q1 2013 Results June 4thh, 2013 Q1 2013 R Results sults 9The Q1 Report This Document includes the Q1 2013 financial statements andd the th managementt report. This document should not be distributed with hout Cegedim authorization – Copyright 2013 14
Slide 15: Appendix
Appe endix
Slide 16: Revenue & Organic Growth Calculation
Revenue & Organic Growth Calculation C Q1‐2013 Division 1 Division 2 Division 3 Group 2012 Revenue a 111,092 67,296 35,817 214,205 Impact of disposals (1,547) 0 0 (1,547) 2012 Revenue before impact of disposals 109,545 67,296 35,817 212,658 Currency impact (1,556) (322) (5) (1,883) 2012 Revenue at
Slide 17: Revenue by Division and by Quarter
Revenue by Division and by Quarter Year 2013 Q1 Q2 Q3 Q4 Total CRM and Strategic Data 104,641 104,641 Healthcare Professionals 71,032 71,032 Insurance and Services 37,192 37,192 Cegedim 212,865 212,865 Year 2012 Q1 Q2 Q3 Q4 Total CRM and Strategic Data 111,092 126,106 111,113 139,834 488,145 Healt
Slide 18: Business Seasonality
Business Seasonality 9 Traditionally higher sales on software at a the end of the year 9 Spending of remaining operating budget 9 More use of data and market research ini Q4 due to the reorganization of sales force organization of new campaign, force, campaign annual a reporting reporting,… This d
Slide 19: Mid-Term Financial Goals
Mid-Term Financial Goals Restore Profitability y 9 Restore profitability to 2009 level Increase Cash-Flow Cash Flow Generation 9 Increase cash conversion ratio Focus on Debt Reduction 9 Reach a leverage ratio of 2.0x Priority to Organic Growth 9 No acquisitions in 2013 This document should
Slide 20: Cegedim at a Glance
Cegedim at a Glance This document should not be distributed with hout Cegedim authorization – Copyright 2013 20
Slide 21: 2013 Financial Agenda
2013 Financial Agenda This document should not be distributed with hout Cegedim authorization – Copyright 2013 21
Slide 22: Keep in Touch with Cegedim
Keep in Touch with Cegedim This document should not be distributed with hout Cegedim authorization – Copyright 2013 22
Slide 23: We welcome your questions and comments
We we W elcome l your questions ti and d comments t Jan Eryyk UMIASTOWSKI Chief In n estment Officer nvestment Head of Investor Relations Janeryk Ja e yk.umiastowski@cegedim.com u asto s @ceged co www.ceegedim.com/finance TEL: +3 33 (0) 1 49 09 33 36